Treatment of atopic dermatitis with mycophenolate mofetil [5]

British Journal of Dermatology

Volumn 143, Issue 6, 2000, Pages 1324-1326

  Hansen, E R ^b   Buus, S ^a   Deleuran, M ^b   Andersen, K E ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETAMETHASONE VALERATE; CHLOROQUINE; CYCLOSPORIN; EMOLLIENT AGENT; ETRETIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TETRACYCLINE;

ADULT; AGED; ATOPIC DERMATITIS; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTACT DERMATITIS; DERMATITIS; DISEASE SEVERITY; DRUG INDUCED DISEASE; FEMALE; FEVER; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LEUKOPENIA; MALE; PRIORITY JOURNAL; PUVA; STEROID THERAPY; TREATMENT OUTCOME;

EID: 0034522315     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03914.x     Document Type: Letter

References (5)

1. Successful treatment of severe refractory dermatitis with mycophenolate mofetil
2. Diagnostic features of atopic dermatitis
3. European Task Force on Atopic Dermatitis Severity scoring of atopic dermatitis the SCORAD index
4. Compositae in dermatitis in a Danish dermatology department in one year. (I) Results of routine patch testing with sesquiterpene lactones mix supplemented with a patch testing with extracts and sesquiterpene lactones of compositae plants
5. Psoriasis vulgaris treated successfully with mycophenolate mofetil